Guardion Health Sciences to Present at the April 2020 Virtual Investor Summit
15 avr. 2020 09h05 HE
|
Guardion Health Sciences, Inc.
– Presentation with live audio webcast on Wednesday, April 22 at 1:30 PM ET, immediately followed by an interactive Q&A session – San Diego, California, April 15, 2020 (GLOBE NEWSWIRE)...
Guardion Health Sciences Announces Launch of acuMMUNE: An Immuno-Supportive/Anti-Oxidant Complex
14 avr. 2020 11h00 HE
|
Guardion Health Sciences, Inc.
- acuMMUNE now available for sale in the United States through online platforms - San Diego, California, April 14, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the...
Guardion Health Sciences Receives Initial Order from Malaysian Company for Exclusive Immuno-Supportive Formula
01 avr. 2020 07h00 HE
|
Guardion Health Sciences, Inc.
--Initial order for $875,000 from Astramune Sdn Bhd, a subsidiary of Ho Wah Genting Berhad --Formula designed to provide immune-supportive benefits --Formula developed by the Company’s...
Guardion Health Sciences Reports 2019 Year End Results and Provides Corporate Update and Overview
30 mars 2020 09h00 HE
|
Guardion Health Sciences, Inc.
--Growing portfolio of synergistic assets and proprietary technologies --Focusing on scalable market opportunities to drive Company’s growth initiatives --Maintaining vision...
Guardion Health Sciences Granted 180-Day Extension by Nasdaq to Regain Compliance with Bid Price Rule
19 mars 2020 12h05 HE
|
Guardion Health Sciences, Inc.
- No immediate effect on the Company’s Nasdaq listing or the trading of its common stock - San Diego, California, March 19, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or...
Guardion Health Sciences Receives $3.5 Million from Exercise of Warrants
06 mars 2020 08h05 HE
|
Guardion Health Sciences, Inc.
San Diego, California, March 06, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), an ocular health sciences company that develops, formulates,...
Guardion Health Sciences Selected by Malaysian Listed Company to Develop an Immuno-Supportive Formula
26 févr. 2020 07h00 HE
|
Guardion Health Sciences, Inc.
Guardion® has signed a Letter of Appointment with Ho Wah Genting Berhad (HWGB) to create a new formula, designed to enhance the immune system.The formula will be a unique and exclusive brand of HWGB ...
Guardion® Announces Development of Unique Immuno-Supportive Complex Targeting Upper Respiratory Tract Infections
06 févr. 2020 07h00 HE
|
Guardion Health Sciences, Inc.
Formulation will be First Nutraceutical Compound to be Introduced Under Guardion’s Recently Acquired NutriGuard Business Line San Diego, California, Feb. 06, 2020 (GLOBE NEWSWIRE) --...
Guardion® Appoints Experienced Executive to Lead Development and Expansion of Recently-Acquired NutriGuard Business Line
07 janv. 2020 11h02 HE
|
Guardion Health Sciences, Inc.
San Diego, California, Jan. 07, 2020 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a leader in the field of ocular health technologies and...
Guardion Health Sciences Closes $8.4 Million Underwritten Public Offering
30 oct. 2019 12h33 HE
|
Guardion Health Sciences, Inc.
San Diego, CA, Oct. 30, 2019 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), today announced the closing of its previously announced underwritten...